Apr 15 (BNP): India’s electricity demand has yet to stage a strong comeback, with growth remaining inconsistent and below expectations.…
Read MoreBusiness Micro
News Stories
Web3 Summit Returns to Berlin to Champion Digital Freedom
The Web3 Foundation’s flagship event will bring builders, artists, researchers and founders to Berlin on 18 and 19 June 2026…
Read MoreKärcher India Champions ‘Mechanised cleaning’ with Manual vs Mechanised’ Campaign
New Delhi, Apr 15: The recent campaign launched by Kärcher India is known as “True Clean” and encouraging consumers to…
Read MoreFrom AI Ambition to Applied Intelligence at Scale: Sia Reaches a New Milestone with Over 800 Agents in its Agent Store
Business Wire India Sia, an international consulting group specializing in strategy, management, and AI, continues to expand its leadership in…
Read MoreInfogain Relaunches as Tenarai to Accelerate Enterprise AI Adoption
Business Wire India Infogain today announced its relaunching as Tenarai, an enterprise AI acceleration company. Tenarai is already the trusted…
Read MoreBihar Gets New CM as Samrat Choudhary Replaces Nitish Kumar
Apr 15 (BNP): Bihar has witnessed a major political shift as Nitish Kumar stepped down from the post of Chief…
Read MoreSensex, Nifty Rally Strongly on Optimism Over West Asia Stability
New Delhi, April 15 (BNP): Indian equity markets witnessed a sharp upswing, with the BSE Sensex surging over 1,100 points…
Read MoreZaheer Ebtikar Joins Plasma as Chief Strategy Officer, Strengthening Leadership Ahead of Plasma One Launch
Business Wire India Plasma, the company behind the first stablecoin-native neobank and the infrastructure powering it, has announced the appointment…
Read MoreKashiv BioSciences Strengthens Executive Leadership with New Chief Operating Officer and Senior Vice President of Regulatory Affairs
Business Wire India Kashiv BioSciences, LLC (“Kashiv”), a vertically integrated biopharmaceutical company, today announced the appointment of Viet Nguyen as…
Read MoreSamsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate
Business Wire India Samsung Bioepis Co., Ltd. announced today the initiation of Phase 1 clinical trial for SBE303. SBE303 is…
Read More